Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MTD, Wadden TA, Wharton S, Yokote K, Zeuthen N, Kushner RF., STEP 1 Study Group
Plaintiffs say the companies failed to warn about severe stomach and bowel injuries, including gastroparesis, bowel obstruction, and lasting vomiting
Updated Phase 3 Data from 2025: The Numbers Got Even Better In December 2025, Eli Lilly released topline results from the TRIUMPH-4 Phase 3 trial, and the numbers exceeded even the most optimistic projections from Wall Street analysts
How long will I need to take GLP-1s
Heres how our process works to ensure you receive effective, personalized care: Many men hate going to the Doctor to discuss some of their personal issues
Genetic variation of promoter sequence modulates XBP1 expression and genetic risk for vitiligo